Noninvasive and Targeted Drug Delivery to the Brain Using Focused Ultrasound

Alison Burgess; Kullervo Hynynen

doi:10.1021/cn300191b

journal article Feb 04, 2013

Noninvasive and Targeted Drug Delivery to the Brain Using Focused Ultrasound

Alison Burgess Kullervo Hynynen

ACS Chemical Neuroscience Vol. 4 No. 4 pp. 519-526 · American Chemical Society (ACS)

View at Publisher Save 10.1021/cn300191b

Topics

No keywords indexed for this article. Browse by subject →

References

87

[1]

Olesen J. Eur. J. Neurol. (2003) 10.1046/j.1468-1331.2003.00682.x

[2]

The blood-brain barrier: Bottleneck in brain drug development

William M. Pardridge

NeuroRX 2005 10.1602/neurorx.2.1.3

[3]

Structure and function of the blood–brain barrier

N. Joan Abbott, Adjanie A.K. Patabendige, Diana E.M. Dolman et al.

Neurobiology of Disease 2010 10.1016/j.nbd.2009.07.030

[4]

Zlokovic B. V. Neuron (2008) 10.1016/j.neuron.2008.01.003

[5]

Abbott N. J. Nat. Rev. Neurosci. (2006) 10.1038/nrn1824

[6]

Schinkel A. H. Cell (1994) 10.1016/0092-8674(94)90212-7

[7]

Higgins C. F. Nature (2007) 10.1038/nature05630

[8]

Reichert J. M. Curr. Pharm. Biotechnol. (2008) 10.2174/138920108786786358

[9]

Leader B. Nat. Rev. Drug Discovery (2008) 10.1038/nrd2399

[10]

Pardridge W. M. Methods Enzymol. (2012) 10.1016/b978-0-12-396962-0.00011-2

[11]

Malerba F. Expert Opin. Drug Delivery (2011) 10.1517/17425247.2011.588204

[12]

Danielyan L. Rejuvenation Res. (2011) 10.1089/rej.2010.1130

[13]

Lochhead J. J. Adv. Drug Delivery Rev. (2012) 10.1016/j.addr.2011.11.002

[14]

Pardridge W. M. J. Cereb. Blood Flow Metab. (2012) 10.1038/jcbfm.2012.126

[15]

Tuszynski M. H. Nat. Med. (2005) 10.1038/nm1239

[16]

Richards Grayson A. C. Nat. Mater. (2003) 10.1038/nmat988

[17]

Raghavan R. Neurosurg. Focus (2006) 10.3171/foc.2006.20.4.7

[18]

Kunwar S. Neurooncology (2010)

[19]

Rapoport S. I. Expert Opin. Invest. Drugs (2001) 10.1517/13543784.10.10.1809

[20]

Matsukado K. Brain Res. (1998) 10.1016/s0006-8993(97)01502-3

[21]

Hanig J. P. Eur. J. Pharmacol. (1972) 10.1016/0014-2999(72)90134-3

[22]

Broadwell R. D. Science (1982) 10.1126/science.7089551

[23]

Hynynen K. Radiology (2001) 10.1148/radiol.2202001804

[24]

McDannold N. Ultrasound Med. Biol. (2005) 10.1016/j.ultrasmedbio.2005.07.010

[25]

Vykhodtseva N. Ultrasound Med. Biol. (1995) 10.1016/0301-5629(95)00038-s

[26]

Mesiwala A. Ultrasound Med. Biol. (2002) 10.1016/s0301-5629(01)00521-x

[27]

Hosseinkhah N. Phys. Med. Biol. (2012) 10.1088/0031-9155/57/3/785

[28]

Bing K. F. Ultrasound Med. Biol. (2009) 10.1016/j.ultrasmedbio.2009.03.012

[29]

O’Reilly M. A. Int. J. Hyperthermia (2012) 10.3109/02656736.2012.666709

[30]

Krasovitski B. IEEE Trans. Ultrason. Ferroelectrics, Frequency Cont (2004) 10.1109/tuffc.2004.1324401

[31]

Caskey C. F. J. Acoust. Soc. Am. (2007) 10.1121/1.2747204

[32]

Klotz A. R. Phys. Med. Biol. (2010) 10.1088/0031-9155/55/6/001

[33]

Liu H-L Ultrasound Med. Biol. (2010) 10.1016/j.ultrasmedbio.2009.10.004

[34]

McDannold N. Ultrasound Med. Biol. (2008) 10.1016/j.ultrasmedbio.2007.10.016

[35]

O’Reilly M a Ultrasound Med. Biol. (2011) 10.1016/j.ultrasmedbio.2011.01.008

[36]

Choi J. J. J. Cereb. Blood Flow Metab. (2011) 10.1038/jcbfm.2010.155

[37]

McDannold N. Ultrasound Med. Biol (2008) 10.1016/j.ultrasmedbio.2007.11.009

[38]

Choi J. J. IEEE Trans. Biomed. Eng. (2010) 10.1109/tbme.2009.2034533

[39]

Vlachos F. Magn. Reson. Med. (2011) 10.1002/mrm.22848

[40]

O’Reilly M. A. Radiology (2012) 10.1148/radiol.11111417

[41]

Thévenot E. Hum. Gene Ther. (2012) 10.1089/hum.2012.013

[42]

Jordão J. F. PloS one (2010) 10.1371/journal.pone.0010549

[43]

Sheikov N. Ultrasound Med. Biol. (2008) 10.1016/j.ultrasmedbio.2007.12.015

[44]

Alonso A. Brain Res. (2011) 10.1016/j.brainres.2011.07.006

[45]

Howles G. P. Magn. Reson. Med. (2010) 10.1002/mrm.22411

[46]

McDannold N. Cancer Res. (2012) 10.1158/0008-5472.can-12-0128

[47]

Sheikov N. Ultrasound Med. Biol. (2006) 10.1016/j.ultrasmedbio.2006.05.015

[48]

Sheikov N. Ultrasound Med. Biol. (2004) 10.1016/j.ultrasmedbio.2004.04.010

[49]

van Wamel A. J. Controlled Release (2006) 10.1016/j.jconrel.2006.02.007

[50]

Meijering B. D. Circ. Res. (2009) 10.1161/circresaha.108.183806

Showing 50 of 87 references

Cited By

117

Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma

Lauren M. Arms, Ryan J. Duchatel · 2024

Journal of Controlled Release

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

Sepand Tehrani Fateh, Lida Moradi · 2021

Beilstein Journal of Nanotechnology

An Advanced In Situ Magnetic Resonance Imaging and Ultrasonic Theranostics Nanocomposite Platform: Crossing the Blood–Brain Barrier and Improving the Suppression of Glioblastoma Using Iron-Platinum Nanoparticles in Nanobubbles

Ming-Hsien Chan, William Chen · 2021

ACS Applied Materials & Interfa...

Metrics

117

Citations

87

References

Details

Published: Feb 04, 2013
Vol/Issue: 4(4)
Pages: 519-526

Authors

A

Alison Burgess

Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada

K

Kullervo Hynynen

Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada; Medical Biophysics and Institute of Biomaterials & Biomedical Engineering (IBBME), University of Toronto, Toronto, Ontario, Canada

Cite This Article

Alison Burgess, Kullervo Hynynen (2013). Noninvasive and Targeted Drug Delivery to the Brain Using Focused Ultrasound. ACS Chemical Neuroscience, 4(4), 519-526. https://doi.org/10.1021/cn300191b

Noninvasive and Targeted Drug Delivery to the Brain Using Focused Ultrasound

You May Also Like